期刊文献+

多西他赛联合照射对人胃癌裸鼠移植瘤生物效应的实验研究

Effects of docetaxel combined with radiotherapy on gastric cancer xenograft in nude mice
下载PDF
导出
摘要 目的:观察多西他赛对人胃癌裸鼠移植瘤的放射增敏作用和多西他赛联合放射对肿瘤细胞凋亡的影响。方法:建立人AGS胃癌裸鼠移植瘤动物模型28只,随机分为4组:对照组、单纯照射组、单纯多西他赛组、多西他赛+照射组。测量各组移植瘤体积,计算各组抑瘤率,评价多西他赛的放射增敏效果,并对标本进行光镜观察及原位末段标记(TUNEL)检测。结果:28只裸鼠的成瘤率为100%,实验期间无死亡,比较各组移植瘤体积差异有统计学意义(P<0.01)。各组抑瘤率分别为单纯照射组36.4%,单纯多西他赛组44.2%,多西他赛+照射组86.9%。多西他赛对放射治疗的增敏值(enhancement factor,EF)值为1.5。多西他赛+照射组的平均凋亡指数(AI)为(15.6±2.3)%,与其它各组比较差异有统计学意义(P<0.01)。结论:多西他赛对人AGS胃癌裸鼠移植瘤有良好的放射增敏作用,多西他赛联合放疗能更有效地诱导肿瘤细胞凋亡。 Objective To investigate the radiosensitizing effect of docetaxel on gastric cancer xenograft in nude mice and the induction of apoptosis by docetaxel combined with radiotherapy. Methods The animal models of xenotransplanted human gastric cancer cell line AGS was set up in 28 nude mice which were divided into 4 groups at random. :the control group,radiation group, docetaxel group and docetaxel plus radiation group. The tumor mass volume was observed in all the groups and the inhibition rate for tumor growth calculated, The effect of radiation enhancement of docetaxel was assessed.The specimens obtained from the nude mice were then detected by optical microscope and TdT- mediated dUTP nick end labeling (TUNEL). Results The mass of gastric tumor was formed in all the nude mice,and none of the mice died.The difference in the volume of tumor formation was significant between the groups, P〈0.01. The rate of tumor inhibition in the radiation group, docetaxel group and docetaxel plus radiation group were 36.4%,44.2%, 86.9%,respectively.EF(enhancement factor) was 1.5 in the docetaxel plus radiation group.The average apoptosis index(AI) in the docetaxel plus radiation group was (15.6±2.3)%,which was higher than the other groups (P〈0.01). Conclusions Docetaxel has an evident radiosensitizing effect on gastric cancer xenograft in the nude mice. As compared to docetaxel alone or radiation alone, docetaxel combined with radiotherapy is more efficient in inducing tumor cell apoptosis.
出处 《外科理论与实践》 2007年第3期260-263,共4页 Journal of Surgery Concepts & Practice
关键词 胃肿瘤 多西他赛 放射疗法 小鼠 Stomach neoplasms Docetaxel Radiotherapy Mice, nude
  • 相关文献

参考文献17

  • 1尹浩然,李琛.胃癌外科治疗[M]//朱正纲 主编.胃肠道肿瘤外科综合治疗新技术.北京:人民军医出版社,2002:111.
  • 2Macdonald JS,Smalley SR,Benedetti J,et al.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction[J].N Engl J Med,2001,345(10):725-730.
  • 3Ajani JA.Docetaxel for gastric and esophageal carcinomas[J].Oneology(Williston Park),2002,16(6 Suppl 6):89-96.
  • 4何东峰,李光.泰索帝放射增敏作用的动物实验研究[J].中华放射肿瘤学杂志,2006,15(6):519-520. 被引量:2
  • 5Ogata T,Araki K,Matsuura K,et al.A 10-year experience of intraoperative radiotherapy for gastric carcinoma and a new surgical method of creating a wider irradiation field for cases of total gastrectomy patients[J].Int J Radiat Oncol Biol Phys,1995,32(2):341-347.
  • 6Safran H,Wanebo HJ,Hesketh PJ,et al.Paclitaxel and concurrent radiation for gastric cancer[J].Int J Radiat Oncol Biol Phys,2000,46(4):889-894.
  • 7沈瑜.改变放射效应的措施[M]//殷蔚伯,谷铣之 主编.肿瘤放射治疗学.第3版.北京:中国协和医科大学出版社.2002:373-374.
  • 8Lavelle F,Bissery MC,Combeau C,et al.Preclinical evaluation of docetaxel(Taxotere)[J].Semin Oncol,1995,22(Suppl 4):3-16.
  • 9Roth AD,Maibach R,Martinelli G,et al.Docetaxel (Taxotere)-cisplatin(TC):an effective drug combination in gastric carcinoma.Swiss Group for Clinical Cancer Research (SAKK),and the European Institute of Oncology(EIO)[J].Ann Oncol,2000,11(3):301-306.
  • 10Adjei AA,Argiris A,Murren JR.Doeetaxel and irinotecan,alone and in combination,in the treatment of non-small cell lung cancer[J].Semin Oncol,1999,26(16):32-40.

二级参考文献24

  • 1顾菲,李光,唐秋,张硕,姚雷,张娜.泰索帝对人鼻咽癌细胞系放射增敏作用机制的初步研究[J].中华放射肿瘤学杂志,2005,14(2):123-124. 被引量:10
  • 2SULKED,A,SMYTH J,SESSA C,et a1.Docetaxel(Taxotere) in advanced gastric cancer;results of a phase Ⅱ clinical trial.EORTC Early Clinical Trials Group[J].Br J Cancer,1994,70:380—383.
  • 3TAGUCHI T,SAKATA Y,KANAMARU R,et a1.Late phase Ⅱ clinical study of RP56976(docetaxel)in patients with advanced/recurrent gastric Cancer:a Japanese Cooperative Study Group trial (group A)[J].Gan To Kagaku Ryoho,1998,25:1915—1924.
  • 4BANG Y J,KANG W K,KANG Y K.Docetaxel 75 ms/m^2 is active and well tolerated in patients with metastatic or recurrent gastric cancer:a phase Ⅱ trial[J].Jpn J Clin Oncol,2002,32:248—254.
  • 5AJANI J A.Docetaxel for gastric and esophageal carcinomas[J]. Ontology(Huntingt),2002,6:89-96.
  • 6MITACHIY,SAKATAY,OHTSUA,et a1.Docetaxel and cispla.tin in patients with advanced or recurrent gastric canceri a multicenter phase I/Ⅱ study[J].Gastric Cancer,2002,5:160-167.
  • 7HAlJ.ER D G,MISSET J L.Docetaxel in advanced gastric cancer[J].Anticancer Drugs,2002,13:451-460.
  • 8ROTH A D,MAIBACH R,MARTINELLI G,et a1.DoceLaxel (Taxotere)-cisplatin(TC):an effective drug combination in gastric carcinoma.Swiss Group for Clinical Cancer Research(SAKK),and the European Institute of Oncology(EIO)[J].Ann Oncol,2000,11:301—306.
  • 9RIDWELSKI K, GEBAUER T, FAHLKE J, et al. Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer[J]. Ann Oncol,2001,12:47-51.
  • 10CONSIENLA M, GARCIA ARROYO R, LORENZO I, et al. Docetaxel, 5-fluomuracil, and leucovorin as treatment for advanced gastric cancer: results of a phase Ⅱ study[J]. Gastric Cancer, 2002,5 : 142-147.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部